chr17-78894782-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001243540.2(CEP295NL):​c.45-2323T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.273 in 152,004 control chromosomes in the GnomAD database, including 9,578 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.27 ( 9578 hom., cov: 32)

Consequence

CEP295NL
NM_001243540.2 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.314

Publications

16 publications found
Variant links:
Genes affected
CEP295NL (HGNC:44659): (CEP295 N-terminal like) Predicted to enable microtubule binding activity. Predicted to be involved in regulation of centriole replication. Predicted to be located in motile cilium. Predicted to be active in centriole; centrosome; and cytosol. [provided by Alliance of Genome Resources, Apr 2022]
TIMP2 (HGNC:11821): (TIMP metallopeptidase inhibitor 2) This gene is a member of the TIMP gene family. The proteins encoded by this gene family are natural inhibitors of the matrix metalloproteinases, a group of peptidases involved in degradation of the extracellular matrix. In addition to an inhibitory role against metalloproteinases, the encoded protein has a unique role among TIMP family members in its ability to directly suppress the proliferation of endothelial cells. As a result, the encoded protein may be critical to the maintenance of tissue homeostasis by suppressing the proliferation of quiescent tissues in response to angiogenic factors, and by inhibiting protease activity in tissues undergoing remodelling of the extracellular matrix. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.99).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.629 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001243540.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CEP295NL
NM_001243540.2
MANE Select
c.45-2323T>C
intron
N/ANP_001230469.1
TIMP2
NM_003255.5
MANE Select
c.131-20863T>C
intron
N/ANP_003246.1
CEP295NL
NM_001243541.2
c.-191-2262T>C
intron
N/ANP_001230470.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CEP295NL
ENST00000322630.3
TSL:2 MANE Select
c.45-2323T>C
intron
N/AENSP00000312767.2
TIMP2
ENST00000262768.11
TSL:1 MANE Select
c.131-20863T>C
intron
N/AENSP00000262768.6
CEP295NL
ENST00000590267.6
TSL:2
c.-191-2262T>C
intron
N/AENSP00000516640.1

Frequencies

GnomAD3 genomes
AF:
0.272
AC:
41373
AN:
151888
Hom.:
9546
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.635
Gnomad AMI
AF:
0.175
Gnomad AMR
AF:
0.158
Gnomad ASJ
AF:
0.107
Gnomad EAS
AF:
0.271
Gnomad SAS
AF:
0.241
Gnomad FIN
AF:
0.125
Gnomad MID
AF:
0.212
Gnomad NFE
AF:
0.115
Gnomad OTH
AF:
0.235
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.273
AC:
41457
AN:
152004
Hom.:
9578
Cov.:
32
AF XY:
0.271
AC XY:
20132
AN XY:
74314
show subpopulations
African (AFR)
AF:
0.635
AC:
26275
AN:
41370
American (AMR)
AF:
0.157
AC:
2402
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.107
AC:
373
AN:
3472
East Asian (EAS)
AF:
0.272
AC:
1406
AN:
5174
South Asian (SAS)
AF:
0.240
AC:
1158
AN:
4818
European-Finnish (FIN)
AF:
0.125
AC:
1319
AN:
10572
Middle Eastern (MID)
AF:
0.201
AC:
59
AN:
294
European-Non Finnish (NFE)
AF:
0.115
AC:
7793
AN:
68004
Other (OTH)
AF:
0.242
AC:
512
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1138
2275
3413
4550
5688
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
376
752
1128
1504
1880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.142
Hom.:
6140
Bravo
AF:
0.290
Asia WGS
AF:
0.298
AC:
1043
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.99
CADD
Benign
3.6
DANN
Benign
0.35
PhyloP100
0.31
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2376999; hg19: chr17-76890864; API